0001225208-17-009791.txt : 20170515 0001225208-17-009791.hdr.sgml : 20170515 20170515172748 ACCESSION NUMBER: 0001225208-17-009791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170512 FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VON SCHACK WESLEY W CENTRAL INDEX KEY: 0001025355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 17846050 MAIL ADDRESS: STREET 1: ENERGY EAST CORP STREET 2: PO BOX 3287 CITY: ITHACA STATE: NY ZIP: 14852-3287 4 1 doc4.xml X0306 4 2017-05-12 0001099800 Edwards Lifesciences Corp EW 0001025355 VON SCHACK WESLEY W ONE EDWARDS WAY IRVINE CA 92614 1 Common Stock 2017-05-12 4 A 0 2034.0000 0.0000 A 2034.0000 D Common Stock 2017-05-12 4 A 0 588.0000 0.0000 A 2622.0000 D Common Stock 40306.0000 I By Trust These restricted stock units were granted on May 12, 2017 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program. They are scheduled to become vested 100% after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the reporting person ceases to serve on Issuer's Board. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it includes 2,524 shares previously reported as directly held. This restricted stock was granted on May 12, 2017 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or Issuer's next annual meeting of stockholders. Ifigenia Protopappas, Attorney-in-fact 2017-05-15